LTR Pharma Ltd: Reinstatement to quotation
LTR Pharma Ltd: SPONTAN achieves positive clinical study results
LTR Pharma Ltd: Suspension from Quotation
LTR Pharma Ltd: Trading Halt
LTR Pharma Ltd: Response to ASX Price Query
LTR Pharma Ltd: Quarterly Activities/Appendix 4C Cash Flow Report
LTR Pharma Ltd: Final Patients dosed in SPONTAN pivotal study
LTR Pharma Ltd: First patients dosed in SPONTAN pivotal study
LTR Pharma Ltd: Recruitment commences for SPONTAN Clinical Study
LTR Pharma Ltd: SPONTAN Achieves Key Manufacturing Validation
LTR Pharma Ltd: Quarterly Activities/Appendix 4C Cash Flow Report
LTR Pharma Ltd: Response to ASX Query Letter
LTR Pharma Ltd: Positive Clinical Data presented at the WMSM in Dubai
LTR Pharma Ltd: Initial Director's Interest Notice - M McGuire
LTR Pharma Ltd: Initial Director's Interest Notice - J Chick
LTR Pharma Ltd: Initial Director's Interest Notice - L Rodne
LTR Pharma Ltd: Investor Webinar
LTR Pharma Ltd: LTR Pharma to List on the ASX
LTR PHARMA LIMITED: Corporate Governance Plan
LTR PHARMA LIMITED: Pre-Quotation Disclosure
No Data